CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
第一著者: | Eva, Israt Ara Jannat |
---|---|
その他の著者: | Rahman, Kazi Fatema |
フォーマット: | 学位論文 |
言語: | English |
出版事項: |
Brac University
2023
|
主題: | |
オンライン・アクセス: | http://hdl.handle.net/10361/17764 |
類似資料
-
A review on CRISPR-Cas system based applications in Oncology
著者:: Sadia, Mir
出版事項: (2022) -
CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
著者:: Maria, Amatul
出版事項: (2020) -
Comparative analysis of CRISPR-Cas systems of Yersinia pestis and Escherichia coli strains. (November 2020 – December 2021)
著者:: Nwabunwanne, Eze Uchenna
出版事項: (2022) -
Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
著者:: Shaikat, Mahdi Mubin
出版事項: (2023) -
CRISPR/Cas9 genome editing to treat sickle cell disease
著者:: Ullah, Mohammad
出版事項: (2023)